Companies included in LABU
This is LABU's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–100 of 161.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| DREYFUS GOVERNMENT CASH MANAGE | DREYFUS GOVERNMENT CASH MANAGE | 40,990,416.22 | PA | 7.899642% |
| GOLDMAN FINANCIAL | GOLDMAN FINANCIAL | 34,559,954.16 | PA | 6.660368% |
| N/A | N/A | 1 | NC | 2.780034% |
| GOLDMAN SACHS LIQ ES FD A | GOLDMAN SACHS LIQ ES FD A | 9,422,418.66 | PA | 1.815881% |
| APLS | Apellis Pharmaceuticals Inc | 194,250 | NS | 1.532992% |
| N/A | N/A | 1 | NC | 1.520455% |
| RVMD | Revolution Medicines Inc | 48,748 | NS | 1.353961% |
| TVTX | Travere Therapeutics Inc | 164,067 | NS | 1.331787% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 83,558 | NS | 1.183266% |
| TWST | Twist Bioscience Corporation | 103,603 | NS | 1.16703% |
| SMMT | Summit Therapeutics Inc. | 278,847 | NS | 1.153243% |
| ALKS | Alkermes PLC | 174,823 | NS | 1.135749% |
| TGTX | TG Therapeutics Inc | 173,080 | NS | 1.12676% |
| MDGL | Madrigal Pharmaceuticals Inc | 11,249 | NS | 1.121649% |
| N/A | N/A | 1 | NC | 1.101713% |
| BEAM | Beam Therapeutics Inc. | 186,154 | NS | 1.088103% |
| APGE | Apogee Therapeutics Inc. | 65,006 | NS | 1.038438% |
| SRRK | Scholar Rock Holding Corp. | 112,425 | NS | 1.009874% |
| PRAX | PRAXIS PRECISION MEDICINES INC | 16,345 | NS | 1.004313% |
| EXEL | EXELIXIS INC | 116,281 | NS | 0.99633% |
| MIRM | Mirum Pharmaceuticals Inc. | 52,917 | NS | 0.992379% |
| N/A | N/A | 1 | NC | 0.984621% |
| UTHR | United Therapeutics Corporation | 8,914 | NS | 0.981522% |
| NTRA | Natera Inc. | 24,696 | NS | 0.981197% |
| CELC | Celcuity Inc. | 41,941 | NS | 0.980852% |
| CRSP | CRISPR Therapeutics AG | 97,235 | NS | 0.980802% |
| KRYS | Krystal Biotech Inc | 19,037 | NS | 0.962178% |
| PTGX | Protagonist Therapeutics Inc | 50,321 | NS | 0.959794% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 37,476 | NS | 0.950966% |
| INCY | Incyte Corporation. | 51,287 | NS | 0.941648% |
| CGON | CG Oncology Inc. | 73,170 | NS | 0.941119% |
| CYTK | Cytokinetics Inc | 76,297 | NS | 0.940608% |
| NUVL | NUVALENT INC | 48,521 | NS | 0.937711% |
| IONS | Ionis Pharmaceuticals, Inc. | 64,911 | NS | 0.935218% |
| BBIO | Bridgebio Pharma Inc | 68,003 | NS | 0.931931% |
| PCVX | Vaxcyte Inc | 84,388 | NS | 0.930905% |
| KYMR | Kymera Therapeutics Inc | 59,553 | NS | 0.930441% |
| BIIB | Biogen Inc | 25,484 | NS | 0.929603% |
| COGT | Cogent Biosciences Inc. | 134,554 | NS | 0.928076% |
| PTCT | PTC Therapeutics, Inc. | 73,928 | NS | 0.926932% |
| INSM | Insmed Inc | 34,830 | NS | 0.915103% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 15,151 | NS | 0.903676% |
| ROIV | Roivant Sciences Ltd | 164,121 | NS | 0.902383% |
| HALO | Halozyme Therapeutics Inc | 73,023 | NS | 0.895883% |
| ARQT | Arcutis Biotherapeutics Inc. | 196,991 | NS | 0.881523% |
| SYRE | Spyre Therapeutics Inc | 61,270 | NS | 0.879099% |
| SLNO UR | Soleno Therapeutics Inc | 85,699 | NS | 0.872367% |
| ABBV | AbbVie Inc. | 21,322 | NS | 0.868348% |
| AMGN | Amgen Inc. | 12,853 | NS | 0.857668% |
| REGN | REGENERON PHARMACEUTICALS INC | 6,267 | NS | 0.853967% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 178,057 | NS | 0.847238% |
| ACAD | ACADIA PHARMACEUTICALS INC | 195,542 | NS | 0.846022% |
| RYTM | Rhythm Pharmaceuticals Inc | 53,930 | NS | 0.845603% |
| GILD | Gilead Sciences Inc. | 33,255 | NS | 0.838538% |
| BMRN | Biomarin Pharmaceutical Inc. | 80,485 | NS | 0.836198% |
| VKTX | Viking Therapeutics Inc. | 135,757 | NS | 0.815762% |
| VRTX | VERTEX PHARMACEUTICALS INC | 9,860 | NS | 0.812112% |
| IBRX | ImmunityBio Inc | 587,041 | NS | 0.803252% |
| IMVT | Immunovant Inc | 147,047 | NS | 0.769256% |
| MRNA | Moderna Inc | 86,741 | NS | 0.767963% |
| VERA | Vera Therapeutics Inc. | 109,557 | NS | 0.75186% |
| IMNM | Immunome Inc | 168,145 | NS | 0.743366% |
| IRON | Disc Medicine Inc | 57,978 | NS | 0.736891% |
| VCYT | Veracyte Inc | 112,171 | NS | 0.711648% |
| SRPT | Sarepta Therapeutics Inc | 175,121 | NS | 0.704683% |
| CPRX | Catalyst Pharmaceuticals Inc. | 129,949 | NS | 0.704478% |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 381,305 | NS | 0.673121% |
| DYN | Dyne Therapeutics Inc. | 196,941 | NS | 0.666098% |
| KOD | Kodiak Sciences Inc | 76,962 | NS | 0.644898% |
| RXRX | RECURSION PHARMACEUTICALS INC | 958,574 | NS | 0.639185% |
| GRAL | GRAIL Inc | 59,651 | NS | 0.626296% |
| N/A | N/A | 1 | NC | 0.619295% |
| RCUS | Arcus Biosciences Inc. | 123,926 | NS | 0.609015% |
| AGIO | Agios Pharmaceuticals Inc | 110,585 | NS | 0.596732% |
| DNLI | Denali Therapeutics Inc | 162,191 | NS | 0.585137% |
| N/A | N/A | 1 | NC | 0.579494% |
| ORKA | Oruka Therapeutics Inc | 43,576 | NS | 0.574503% |
| DNTH | Dianthus Therapeutics Inc | 33,605 | NS | 0.568622% |
| NTLA | Intellia Therapeutics Inc | 215,007 | NS | 0.558557% |
| ERAS | Erasca Inc | 271,194 | NS | 0.556615% |
| ADMA | ADMA BIOLOGICS INC | 281,674 | NS | 0.556411% |
| SNDX | Syndax Pharmaceuticals Inc. | 134,242 | NS | 0.554416% |
| ARDX | Ardelyx Inc | 438,991 | NS | 0.535531% |
| IDYA | IDEAYA Biosciences Inc. | 93,300 | NS | 0.523239% |
| MLYS | Mineralys Therapeutics Inc. | 101,556 | NS | 0.521588% |
| NRIX | Nurix Therapeutics Inc. | 160,937 | NS | 0.517961% |
| TNGX | Tango Therapeutics Inc. | 112,975 | NS | 0.47072% |
| CLDX | Celldex Therapeutics Inc. | 70,017 | NS | 0.44367% |
| CAPR | CAPRICOR THERAPEUTICS INC | 67,108 | NS | 0.43429% |
| VCEL | Vericel Corporation | 63,931 | NS | 0.427899% |
| INBX | Inhibrx Biosciences Inc. | 16,961 | NS | 0.42235% |
| GLUE | Monte Rosa Therapeutics Inc | 112,609 | NS | 0.415592% |
| NVAX | Novavax Inc | 267,379 | NS | 0.408368% |
| BHVN | Biohaven Ltd | 220,160 | NS | 0.406895% |
| STOK | Stoke Therapeutics Inc | 64,471 | NS | 0.40654% |
| RLAY | Relay Therapeutics Inc | 162,116 | NS | 0.404908% |
| TSHA | Taysha Gene Therapies Inc. | 322,791 | NS | 0.397509% |
| VRDN | Viridian Therapeutics Inc | 152,815 | NS | 0.396991% |
| OLMA | Olema Pharmaceuticals Inc. | 141,558 | NS | 0.393118% |
| PVLA | Palvella Therapeutics Inc. | 15,705 | NS | 0.38838% |
SEC N-PORT snapshot as of .